Clinical Trials Directory

Trials / Terminated

TerminatedNCT02691117

Topical Garlic Concentrate for Alopecia Areata in Children

Topical Garlic Concentrate for Alopecia Areata in Children: A Prospective Open Label Study

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Elena Pope · Academic / Other
Sex
All
Age
4 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Management of pediatric alopecia is particularly challenging given the chronicity of the condition, limited therapeutic response and devastating psychological effects. There is a paucity of safe and effective therapies in this population. The investigators propose to conduct and open label, prospective cohort pilot study using topical garlic concentrate ( GarlicRich) for treatment of children with alopecia areata. Study medication will be applied topically on affected area of the skin daily for 6 months. Follow up visits will occur monthly to access the efficacy and safety of the proposed treatment .

Detailed description

The investigators are planning to enroll in the study 20 participants at Sickkids. It is an open label, prospective cohort pilot study. Patients enrolled in the study will be followed at the Hospital for Sick Children for 6 months. Participants will come for the study visits every month (7 study visits). During each study visit two investigators will independently access patient's hair density and calculate the SALT score (Severity of Alopecia Tool Score), using the participant's digital photographs. Patients will be provided with the study medication for all duration of the study. The results of the treatment will be compared with the baseline data ( pictures/ scores/ hair density) to evaluate the efficacy and safety of garlic concentrate in children with patchy alopecia areata.

Conditions

Interventions

TypeNameDescription
DRUGgarlic concentrateTopical application of GarlicRich gel on the scalp areas affected with alopecia areata once a day for 6 months

Timeline

Start date
2016-01-10
Primary completion
2017-08-15
Completion
2017-12-01
First posted
2016-02-25
Last updated
2018-04-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02691117. Inclusion in this directory is not an endorsement.